Literature DB >> 11740894

The first in vivo observation of (13)C-(15)N coupling in mammalian brain.

K Kanamori1, B D Ross.   

Abstract

[5-(13)C,(15)N]Glutamine, with (1)J((13)C-(15)N) of 16 Hz, was observed in vivo in the brain of spontaneously breathing rats by (13)C MRS at 4.7 T. The brain [5-(13)C]glutamine peak consisted of the doublet from [5-(13)C,(15)N]glutamine and the center [5-(13)C,(14)N]glutamine peak, resulting in an apparent triplet with a separation of 8 Hz. The time course of formation of brain [5-(13)C,(15)N]glutamine was monitored in vivo with a time resolution of 20-35 min. This [5-(13)C,(15)N]glutamine was formed by glial uptake of released neurotransmitter [5-(13)C]glutamate and its reaction with (15)NH(3) catalyzed by the glia-specific glutamine synthetase. The neurotransmitter glutamate C5 was selectively (13)C-enriched by intravenous [2,5-(13)C]glucose infusion to (13)C-label whole-brain glutamate C5, followed by [(12)C]glucose infusion to chase (13)C from the small and rapidly turning-over glial glutamate pool, leaving (13)C mainly in the neurotransmitter [5-(13)C]glutamate pool, which is sequestered in vesicles until release. Hence, the observed [5-(13)C,(15)N]glutamine arises from a coupling between (13)C of neuronal origin and (15)N of glial origin. Measurement of the rate of brain [5-(13)C,(15)N]glutamine formation provides a novel noninvasive method of studying the kinetics of neurotransmitter uptake into glia in vivo, a process that is crucial for protecting the brain from glutamate excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11740894     DOI: 10.1006/jmre.2001.2432

Source DB:  PubMed          Journal:  J Magn Reson        ISSN: 1090-7807            Impact factor:   2.229


  7 in total

1.  Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.

Authors:  Alexander P Lin; Frederick Shic; Cathleen Enriquez; Brian D Ross
Journal:  MAGMA       Date:  2003-02       Impact factor: 2.310

2.  Electrographic seizures are significantly reduced by in vivo inhibition of neuronal uptake of extracellular glutamine in rat hippocampus.

Authors:  Keiko Kanamori; Brian D Ross
Journal:  Epilepsy Res       Date:  2013-09-01       Impact factor: 3.045

3.  Hypermetabolic state in the 7-month-old triple transgenic mouse model of Alzheimer's disease and the effect of lipoic acid: a 13C-NMR study.

Authors:  Harsh Sancheti; Ishan Patil; Keiko Kanamori; Roberta Díaz Brinton; Wei Zhang; Ai-Ling Lin; Enrique Cadenas
Journal:  J Cereb Blood Flow Metab       Date:  2014-08-06       Impact factor: 6.200

4.  Detection of reduced GABA synthesis following inhibition of GABA transaminase using in vivo magnetic resonance signal of [13C]GABA C1.

Authors:  Jehoon Yang; Christopher Johnson; Jun Shen
Journal:  J Neurosci Methods       Date:  2009-06-21       Impact factor: 2.390

5.  Reversal of metabolic deficits by lipoic acid in a triple transgenic mouse model of Alzheimer's disease: a 13C NMR study.

Authors:  Harsh Sancheti; Keiko Kanamori; Ishan Patil; Roberta Díaz Brinton; Brian D Ross; Enrique Cadenas
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-13       Impact factor: 6.200

6.  Faster flux of neurotransmitter glutamate during seizure - Evidence from 13C-enrichment of extracellular glutamate in kainate rat model.

Authors:  Keiko Kanamori
Journal:  PLoS One       Date:  2017-04-12       Impact factor: 3.240

7.  Brain metabolic and functional alterations in a liver-specific PTEN knockout mouse model.

Authors:  Ishan Patil; Harsh Sancheti; Bangyan L Stiles; Enrique Cadenas
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.